Adamas Pharmaceuticals, Inc.: accounts_receivable

Value{"amount": 5536000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2019-09-30)
Statuscurrent
EntityAdamas Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001328143-19-000049 · Open the official SEC filing →
Retrieved: 2026-08-19T12:42:20.451056+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001328143/accounts-receivable/2019-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/91f9adee-4a5f-42e4-8ef9-190a01ac5dd0

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies